nav.hidden, nav ul [x-cloak], nav ul li ul { display: block !important; } This website requires Javascript for some parts to function properly. Your experience may vary.

Skip to content

This website uses cookies

This website uses cookies to improve user experience. By using our website you consent to all cookies in accordance with our Cookie Policy.

Essential Essential cookies enable basic functions and are necessary for the website to function properly. Marketing Marketing cookies are used by third parties or publishers to display personalized advertisements. They do this by tracking visitors across websites.

Current Partnerships

Current Partnerships

ITM

SFCCNI

CNL

CNIC

CEOIA

USask

ACSI

R&D

CNL

ITM

SFCCNI

ACSI

USask

Building Canadian Ecosystem

CNIC

CEOIA

Latest News

January 16th, 2025

Actineer Appoints New President and CEO

Actineer, a joint venture between ITM and Canadian Nuclear Laboratories (CNL) Ltd., today announced the appointment of Joseph...

October 17th, 2024

Actineer Advances
Ac-225 Production

Chalk River, Ontario, October 17, 2024 – Actineer, the joint venture between ITM and Canadian Nuclear Laboratories (CNL) Ltd., has...

December 7th, 2023

Actinium-225 production

Toronto – December 7 2023 – In support of Canadian Nuclear Isotope Council’s (CNIC) goal of ensuring a reliable supply of medical...

October 18th, 2023

ITM and CNL Announce the Launch of Actineer

ITM Isotope Technologies Munich SE (ITM), a leading radio- pharmaceutical biotech company, and Canadian Nuclear Laboratories (CNL)